Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TITAN-PARADISE Pilot: TicIn for the Treatment of Coronary Lesions - Plaque Regression and Stabilization With Sirolimus Elution (Pilot Study)

NCT06928883 is registered in ClinicalTrials.gov with Cardiocentro Ticino as lead sponsor.

NCT NCT06928883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06928883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TITAN-PARADISE Pilot: TicIn for the Treatment of Coronary Lesions - Plaque Regression and Stabilization With Sirolimus Elution (Pilot Study)
Lead sponsor
Cardiocentro Ticino
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
December 31, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes (acs), coronary arterial disease (cad), coronary vessel, multivessel coronary artery disease, vulnerable coronary plaques